scholarly journals Effect of Enhydra fluctuans on Kidney Function in Alloxan-induced Diabetic Rats

2021 ◽  
Vol 9 (A) ◽  
pp. 1187-1194
Author(s):  
Rina Delfita ◽  
Dahelmi Dahelmi ◽  
Djong Tjong ◽  
Suhatri Suhatri
Keyword(s):  
Blood Glucose ◽  
Kidney Function ◽  
Quantitative Data ◽  
Diabetic Rats ◽  
Hexane Fraction ◽  
Kidney Cells ◽  
Blood Glucose Profile ◽  
Group 2 ◽  
Range Test ◽  
Group 1

AIM: The aim of this study was to explore the effect of n-hexane fraction of Enhydra fluctuans aerial on kidney function in alloxan induced diabetic rats. METHODS: Five groups of diabetic Wistar rats were studied: Group 1 was given 0.5% Na-CMC (G0), group 2 was given glibenclamide 0.45 mg/kg (G1), groups 3, 4, and 5 were given a dose of n-hexane fraction 57.03, 114.06, and 171.09 mg/kg respectively. The experiment was completed in 21 days. Blood glucose was estimated on day 0 and day 21 of treatment. Histology of kidney, creatinine, and blood urea nitrogen (BUN) was examined. ANOVA was used to evaluate quantitative data, which was then followed by Duncan's new multiple range test (p < 0.05). RESULTS: Our results demonstrate that n-hexane fraction dosages of 57.03 mg/kg and 114,06 mg/kg significantly improved blood glucose profile, BUN, and creatinine in diabetic rats. Moreover, the dosage of 57.03 mg/kg is effective to counteract necrosis and fibrosis of kidney cells.   CONCLUSION: Our findings revealed that the administration of the n-hexane fraction of E. fluctuans aerial improved the kidney function of diabetic rats, especially at the dosage of 57.03 mg/kg. Therefore, E. fluctuans can be relied upon to be a drug to prevent the development of diabetes mellitus and diabetic nephropathy.

scholarly journals Evaluation of Kidney Function Parameters in Diabetic Rats Following Virgin Coconut Oil Diet

Folia Medica ◽  
2019 ◽  
Vol 61 (2) ◽  
pp. 249-257 ◽  
Author(s):  
Akinjide M. Akinnuga ◽  
Olubayode Bamidele ◽  
Anthony J. Adewumi
Keyword(s):  
Kidney Function ◽  
Biochemical Analysis ◽  
Coconut Oil ◽  
Diabetic Rats ◽  
Control Group ◽  
Virgin Coconut Oil ◽  
Normal Rat ◽  
Group 2 ◽  
Diabetes Control Group ◽  
Group 1

Abstract Background: Diabetes mellitus (DM) leads to disruption of kidney function parameters (KFPs) which are markers of kidney diseases, especially nephropathy. Virgin coconut oil (VCO) has been implicated in playing a significant role in DM management. However, its role on KFPs in DM is scarce. Aim: To evaluate the kidney function parameters following VCO diet in diabetic rats. Materials and methods: : Twenty-five (25) male rats of 150 – 200 g were divided into 5 groups (n=5): Non-diabetic control (Group 1), diabetes control (Group 2), diabetes + metformin (Group 3), diabetes + 10% VCO (Group 4) and diabetes + 20% VCO (Group 5). Apart from Group 1, other groups were given intraperitone-ally 50 mg/kg of streptozotocin to induce diabetes mellitus. After 72 hours, fasting hyperglycaemia was confirmed by glucose oxidase method. All the rats were fed normal rat chow for 8 weeks. At 8th week, serum and urine samples were analysed for biochemical analysis. After 8 weeks, Group 1 and Group 2 continued to be fed on normal rat chow while other groups were treated with diets (VCO) or drug (metformin) for 4 weeks. At 12th week, urine samples were collected for biochemical analysis, the rats were sacrificed, and blood samples were collected by cardiac puncture. Results: There were significant differences in some KFPs in diabetes control (Group 2) compared to other experimental groups. However, there was no significant difference in glomerular filtration rate (GFR) and serum sodium in all the groups. Conclusion: VCO supplementary diet improved the altered KFPs and could be a therapy for kidney problems.

scholarly journals The outcome of patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) and impaired kidney function: a 3-year observational study

2021 ◽  
Author(s):  
Malgorzata Zalewska-Adamiec ◽  
Jolanta Malyszko ◽  
Ewelina Grodzka ◽  
Lukasz Kuzma ◽  
Slawomir Dobrzycki ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Incidence Rate ◽  
Kidney Function ◽  
Coronary Arteries ◽  
Left Ventricular ◽  
Left Ventricular Ejection ◽  
Ventricular Ejection Fraction ◽  
Risk Of Death ◽  
Group 2 ◽  
Group 1

Abstract Background Myocardial infarction with nonobstructive coronary arteries (MINOCA) constitutes about 10% of the cases of acute coronary syndromes (ACS). It is a working diagnosis and requires further diagnostics to determine the cause of ACS. Methods In this study, 178 patients were initially diagnosed with MINOCA over a period of 3 years at the Department of Invasive Cardiology of the University Clinical Hospital in Białystok. The value of estimated glomerular filtration rate (eGFR) was calculated for all patients. The patients were divided into 2 groups depending on the value of eGFR: group 1—53 patients with impaired kidney function (eGFR < 60 mL/min/1.73 m2; 29.8%) and group 2—125 patients with normal kidney function (eGFR ≥ 60 mL/min/1.73 m2; 70.2%). Results In group 1, the mean age of patients was significantly higher than that of group 2 patients (77.40 vs 59.27; p < 0.0001). Group had more women than group 2 (73.58% vs 49.60%; p = 0.003). Group 1 patients had higher incidence rate of arterial hypertension (92.45% vs 60.80%; p < 0.0001) and diabetes (32.08% vs 9.60%; p = 0.0002) and smoked cigarettes (22.64% vs 40.80%; p = 0.020). Group 1 patients had higher incidence rate of pulmonary edema, cardiogenic shock, sudden cardiac arrest (13.21% vs 4.00%; p = 0.025), and pneumonia (22.64% vs 6.40%; p = 0.001). After the 37-month observation, the mortality rate of the patients with MINOCA was 16.85%. Among group two patients, more of them became deceased during hospitalization (7.55% vs 0.80%; p = 0.012), followed by after 1 year (26.42% vs 7.20%; p = 0.0004) and after 3 years (33.96% vs 9.6%; p < 0.0001). Multivariate analysis revealed that the factors increasing the risk of death in MINOCA are as follows: older age, low eGFR, higher creatinine concentration, low left ventricular ejection fraction, and ST elevation in ECG. Conclusion Impaired kidney function is diagnosed in every third patient with MINOCA. Early and late prognosis of patents with MINOCA and renal dysfunction is poor, and their 3-year mortality is comparable to patients with myocardial infarction with significant stenosis of the coronary arteries and impaired kidney function.

scholarly journals Influence of subconjunctival steroid injection on blood glucose profile in diabetic rats

Eye ◽  
2001 ◽  
Vol 15 (3) ◽  
pp. 326-328 ◽  
Author(s):  
Harumi Fukushima ◽  
Satoshi Kato ◽  
Yoshie Hayashi ◽  
Tetsuro Oshika
Keyword(s):  
Blood Glucose ◽  
Steroid Injection ◽  
Diabetic Rats ◽  
Glucose Profile ◽  
Blood Glucose Profile

Evaluation of hepatic glycogen content, some haematological and biochemical parameters of alloxan-induced diabetic rats treated with combinations of glibenclamide and G. latifolium extract

2017 ◽  
Vol 14 (4) ◽  
Author(s):  
Patrick E. Aba
Keyword(s):  
Glycogen Content ◽  
Diabetic Rats ◽  
Hepatic Glycogen ◽  
Control Groups ◽  
Group 4 ◽  
Male Wistar Rats ◽  
The Mean ◽  
Group 2 ◽  
Alloxan Monohydrate ◽  
Group 1

AbstractBackgroundDiabetes is associated with both biochemical and haematological complications. Combination therapy has been advocated to mitigate some of these complications.AimThis study was designed to investigate the effects of glibenclamide andMethodsThirty male Wistar rats were assigned into five groups of six rats each. Groups 2–5 rats received intraperitoneally, 160 mg/kg of alloxan monohydrate while group 1 rats served as normal control. Groups 2–5 rats were respectively treated with 10 mL/kg distilled water (DW), 2 mg/kg glibenclamide, 200 mg/kg GL and 2 mg/kg glibenclamide and 200 mg/kg GL, while group 1 rats received 10 mL/kg DW. All treatments wereResultsCreatinine and BUN values of groups 3 and 4 rats were comparable to that of group 1 but were significantly (p<0.05) lower when compared with those of groups 2 and 5. There were significant (p<0.05) increases in the mean hepatic glycogen content, RBC, PCV, and Hb of group 4 rats when compared to those of group 2.ConclusionsIt was concluded that a combination of glibenclamide and

scholarly journals Comparing the effect of ladies’ finger water with fenugreek seeds water on the blood glucose level among subjects with type 2 diabetes mellitus-a randomized controlled trial

2021 ◽  
Vol 8 (1) ◽  
pp. 10
Author(s):  
Radhika R. ◽  
Navaneetha M. ◽  
Ravichandran K. ◽  
Hemavathi P.
Keyword(s):  
Type 2 Diabetes ◽  
Blood Glucose ◽  
Blood Glucose Level ◽  
Glucose Level ◽  
Fenugreek Seeds ◽  
Significant Difference ◽  
Group 3 ◽  
Group 2 ◽  
Group 1

<p><strong>Background: </strong>The primary aim of managing diabetes is to maintain blood glucose level to prevent diabetes induced complications. Studies showed that ladies finger and fenugreek seeds are blood sugar stabilizer. The objective of this randomized active controlled trial was to assess the effect of ladies finger water versus fenugreek seeds water on the blood glucose level among subject with type 2 diabetes.</p><p><strong>Methods: </strong>Total of 180 study participants were selected and equally assigned to three groups by computer generated randomization. Group 1-received ladies finger water and oral antidiabetic drug (OAD); group 2-received fenugreek seeds water and OAD; group 3-received only OAD for 15 days. Pre and post intervention fasting blood sugar (FBS) was assessed by accu-chek Performa glucometer. Wilcoxon signed rank test; one-way analysis of covariance followed by post hoc test with Bon-ferroni correction was done.</p><p><strong>Results: </strong>Analysis was done based on 168 subjects. There was a significant reduction in FBS level with the mean difference of group 1-21.0 mg/dl (p&lt;0.001), group 2-20.3 mg/dl (p&lt;0.001) and group 3-4.7 mg/dl (p=0.068). No significant difference found between group 1 and group 2 (p=1.00), but significant difference found between group 1 and group 3 (p=0.032); group 2 and group 3 (p=0.012). Both ladies finger water and fenugreek seeds water were superior in reduction of FBS than OAD.</p><p><strong>Conclusions: </strong>Ladies finger water or fenugreek seeds water can be used as adjunct along with OAD to control type 2 diabetes mellitus.</p><p><strong> </strong></p>

scholarly journals Study of the effect of vildagliptin, a DPP-IV inhibitor on learning and memory dysfunction of diabetic rats

2017 ◽  
Vol 6 (6) ◽  
pp. 1461
Author(s):  
Trupti Rekha Swain ◽  
Manorama Swain ◽  
Suchismita Pattanaik
Keyword(s):  
Learning And Memory ◽  
Diabetic Rats ◽  
Favorable Effect ◽  
Albino Rats ◽  
Memory Dysfunction ◽  
Dpp Iv ◽  
Y Maze ◽  
Group 2 ◽  
Student’S T ◽  
Group 1

Background: To evaluate whether vildagliptin, DPP-IV inhibitor possess a favorable effect on learning and memory dysfunction in the management of Diabetes mellitus.Methods: Forty Albino rats of either sex weighing 100-180g, were divided into 4 groups of 10 animals each. Streptozotocin was used for induction of diabetes in rats. The rats were divided into 4 groups of eight rats in each. Group-1 was taken as control with no further intervention whereas group-2,3,4 were injected 5mg/kg, 10mg/kg,20mg/kg of vildagliptin respectively for a period of 2 months. At the end of first and second month of treatment period, the rats were subjected to Y maze and EPM tests. The data were analyzed statistically using one-way analysis of variance followed by Student’s t test for paired analysis.Results: There was significant decrease in no of arm entries and SAP (p<0.05) in group-1 with induced diabetes. In addition, there was slight increase in no of open arm entries with time spent in open arm for the same group. The decrease in no of arm entries and SAP progressively declined and the no of open arm entries with time spent in open arm progressively increased from group-2 to group 4 till the end of 1st month. After 2nd month there was further decrease in no of arm entries and SAP (p<0.05) for group-1. There was significant increase in all parameters for rest of the groups after 2nd month as compared to 1st month. The findings clearly infer the potency of vildagliptin in treating diabetes induced learning and memory impairment.Conclusions: Vildagliptin significantly reduces the incidence of diabetes induced memory impairment and improves learning if continued further.

scholarly journals High Fasting Blood Glucose Level With Unknown Prior History of Diabetes Is Associated With High Risk of Severe Adverse COVID-19 Outcome

2021 ◽  
Vol 12 ◽  
Author(s):  
Wenjun Wang ◽  
Zhonglin Chai ◽  
Mark E. Cooper ◽  
Paul Z. Zimmet ◽  
Hua Guo ◽  
...  
Keyword(s):  
Blood Glucose ◽  
Fasting Blood Glucose ◽  
Diabetes Group ◽  
Icu Admission ◽  
Group 4 ◽  
Diabetic Status ◽  
History Of ◽  
Group 3 ◽  
Group 2 ◽  
Group 1

BackgroundWe aimed to understand how glycaemic levels among COVID-19 patients impact their disease progression and clinical complications.MethodsWe enrolled 2,366 COVID-19 patients from Huoshenshan hospital in Wuhan. We stratified the COVID-19 patients into four subgroups by current fasting blood glucose (FBG) levels and their awareness of prior diabetic status, including patients with FBG&lt;6.1mmol/L with no history of diabetes (group 1), patients with FBG&lt;6.1mmol/L with a history of diabetes diagnosed (group 2), patients with FBG≥6.1mmol/L with no history of diabetes (group 3) and patients with FBG≥6.1mmol/L with a history of diabetes diagnosed (group 4). A multivariate cause-specific Cox proportional hazard model was used to assess the associations between FBG levels or prior diabetic status and clinical adversities in COVID-19 patients.ResultsCOVID-19 patients with higher FBG and unknown diabetes in the past (group 3) are more likely to progress to the severe or critical stage than patients in other groups (severe: 38.46% vs 23.46%-30.70%; critical 7.69% vs 0.61%-3.96%). These patients also have the highest abnormal level of inflammatory parameters, complications, and clinical adversities among all four groups (all p&lt;0.05). On day 21 of hospitalisation, group 3 had a significantly higher risk of ICU admission [14.1% (9.6%-18.6%)] than group 4 [7.0% (3.7%-10.3%)], group 2 [4.0% (0.2%-7.8%)] and group 1 [2.1% (1.4%-2.8%)], (P&lt;0.001). Compared with group 1 who had low FBG, group 3 demonstrated 5 times higher risk of ICU admission events during hospitalisation (HR=5.38, 3.46-8.35, P&lt;0.001), while group 4, where the patients had high FBG and prior diabetes diagnosed, also showed a significantly higher risk (HR=1.99, 1.12-3.52, P=0.019), but to a much lesser extent than in group 3.ConclusionOur study shows that COVID-19 patients with current high FBG levels but unaware of pre-existing diabetes, or possibly new onset diabetes as a result of COVID-19 infection, have a higher risk of more severe adverse outcomes than those aware of prior diagnosis of diabetes and those with low current FBG levels.

scholarly journals An Evaluation of Liver Function Tests in SARS-CoV-2 infection in the backdrop of chronic kidney disease

2021 ◽  
Author(s):  
Rajeev Kumar ◽  
Pratip Jana ◽  
Indu Priyadarshini ◽  
SMITA ROY ◽  
Pritha Dutta ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Liver Function ◽  
Kidney Function ◽  
Cross Sectional ◽  
Serum Aminotransferase ◽  
Function Test ◽  
Group 3 ◽  
Group 2 ◽  
Group 1

ABSTRACT INTRODUCTION The SARS-CoV-2 pandemic has emerged as perhaps the most challenging global health problem of this century. The concomitant presence of co morbidities like chronic kidney disease (CKD), diabetes, chronic heart disease etc. makes the task of patient management difficult. AIMS AND OBJECTIVES To assess the patterns of liver test abnormalities in patients of COVID 19 infection with and without CKD and evaluate the probable outcomes. MATERIALs and METHODS A cross-sectional retrospective observational study done on 600 patient samples (Group 1 COVID-19 without CKD, Group 2 COVID-19 with CKD and Group 3 non COVID-19 with CKD) which were processed for Liver function test (AST, ALT and ALP) and Renal function test (Urea and Creatinine) in the Department of Biochemistry, Dr. RML Hospital New Delhi. RESULTS AST and ALT levels were significantly higher (P < 0.05) in all COVID 19 positive patients group 1 mean and 2 SD, (63.63 and 42.89 U/L & 50.25 and 46.53 U/L respectively) and group 2 (90.59 and 62.51 U/L & 72.09 and 67.24 U/L respectively) as compared to Group 3 (25.24 and 7.47 U/L & 24.93 and 11.44 U/L respectively) and also a statistically significant elevation is seen in these two parameters (AST & ALT) in Group 2 as compared to Group 1 (P < 0.05). There was a negative significant correlation between eGFR and AST/ALT levels in Group 1 (p < 0.05). In Group 2, a weak positive correlation was seen with ALT (p < 0.01). No significant correlation existed between eGFR and ALP in groups 1 and 2. In Group 3, eGFR showed strong correlations with AST and ALT levels (p < 0.01) and reduction in kidney function correlated well with increase in serum ALP levels, (p < 0.01). CONCLUSIONS This study most comprehensively describes that SARS-CoV-2 positive CKD patients show more elevations in serum aminotransferase levels as compared to their non-CKD counterparts, in contrast to non-COVID-19 CKD cases. Serum ALT values in SARS-CoV-2 patients show significant correlation with calculated eGFR values. Elevated ALP values in CKD patients may be used as an indicator of declining kidney function. However, more studies in this direction are needed.

scholarly journals Hypertension and cardiometabolic comorbidity in patients with different levels of blood glucose in the non-diabetic range

2020 ◽  
Vol 26 (2) ◽  
pp. 219-229
Author(s):  
I. V. Druk ◽  
M. M. Ibragimova ◽  
D. V. Blazhko ◽  
L. A. Muratova ◽  
O. Yu. Korennova ◽  
...  
Keyword(s):  
Blood Glucose ◽  
Total Cholesterol ◽  
Body Mass ◽  
Metabolic Diseases ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Increased Risk ◽  
Group 2 ◽  
Different Levels ◽  
Group 1

Objective. To study the prevalence of hypertension (HTN), concomitant and associated cardiovascular, metabolic diseases and disorders in people with different levels of blood glucose in the non-diabetic range.Design and methods. A content analysis of 1503 outpatient maps was carried out with the assessment of age, body weight, body mass index (BMI), fasting plasma glucose (FPG), total cholesterol, low density lipoprotein cholesterol (LDL)), overweight/obesity, HTN, atherosclerotic diseases. The changes in carbohydrate metabolism were classified as following: highnormal FPG (5,6-6,0 mmol/l; n = 141; group 1), normoglycemia (FPG up to 5,5 mmol/l; n = 1227; group 2), previously diagnosed prediabetes (n = 54; group 3) and diabetes mellitus (n = 81).Results. Group 1 was characterized by higher body mass, BMI, FPG, total cholesterol, higher prevalence of dyslipidemia, atherosclerotic diseases, overweight/obesity, HTN (p < 0,001) compared with group 2. The presence of a “highnormal level of FPG” is associated with an increased risk of dyslipidemia (relative risk: RR 1,579; 95 % confidence interval (CI): 1,348-1,803), atherosclerotic diseases (RR2,095; 95 % CI 1,371-3,832), obesity (RR 1,766; 95 % CI 1,568-1,934), AH (RR 1,697; 95 % CI 1,45-1,93). Groups 1 and 3 did not differ by the general characteristics. HTN patients in group 1 compared with group 2 more often had dyslipidemia (p = 0,034) and overweight/obesity (p = 0,014). In patients with HTN, the presence of “highnormal FPG” is associated with an increased risk of dyslipidemia (RR 1,221; 95 % CI 1,005-1,429), overweight/obesity (RR 1,189; 95 % CI 1,0291,319). HTN patients in groups 1 and 3 did not differ in the frequency of dyslipidemia, atherosclerotic diseases, overweight/obesity.Conclusions. “Highnormal level of FPG” is associated with an increased risk of dyslipidemia, atherosclerotic diseases, HTN, obesity; among HTN patients—with an increased risk of dyslipidemia, overweight/ obesity. Patients with “highnormal FPG” and patients with prediabetes show similar cardiometabolic status.

Sign in / Sign up

Export Citation Format

Share Document